We're developing a broad portfolio that has the potential to meaningfully improve millions of lives.
Vaxxine Program (Target)
Parkinson’s, DLB, MSA
Vaxxinity is committed to developing safe and effective immunotherapeutic vaccines, with a goal of providing our next generation products as soon as possible through efficient product development. At this time, Vaxxinity’s investigational products can only be accessed through participation in a clinical trial. For detailed information on our ongoing clinical trials, please CLICK HERE. Vaxxinity does not currently offer an expanded access program.